|
March 2018
Chorionic Gonadotropin and Novarel® changing tiers on March 1; cost-effective alternative available
Blue Cross Blue Shield of Michigan and Blue Care Network are moving Chorionic Gonadotropin and Novarel to the nonpreferred tier of all HMO and PPO drug lists; this change will be effective on March 1. Instead of taking Gonadotropin and Novarel, Blue Cross and BCN members can save money by switching to the lower cost alternative, Pregnyl®.
Patients who are prescribed Gonadotropin and Novarel after March 1 will have to pay a higher copayment and these drugs may not be covered for members with a 3-tier closed-benefit plan.
Here is an overview of where these drugs sit within our various pharmacy plans:
Higher-cost drug |
Copayment level |
3-tier plans |
5- and 6-tier plans |
Chorionic Gonadotropin |
Nonpreferred brand
(tier 3) |
Nonpreferred specialty
(tier 5) |
Novarel |
Nonpreferred brand
(tier 3) |
Nonpreferred specialty
(tier 5) |
Lower-cost alternative |
3-tier plans |
5- and 6-tier plans |
Pregnyl® |
Preferred brand
(tier 2) |
Preferred specialty
(tier 4) |
We’ve sent letters to affected Blue Cross and BCN members, notifying them of this change and encouraging them to contact their physicians to discuss switching to the lower-cost alternative. This change does not apply to BCN Advantage or Blue Cross Medicare Part D members.
All of our drugs lists can be found online at bcbsm.com.
| 
